Chikungunya Fever: all 84 studies

Page 1 of 1. Open to participants first (18), then studies with results posted, then the rest; newest registration first within each.

• Evaluation of IXCHIQ® Vaccine ImmunogenicityNot yet recruitingNCT07846293Phase 2
• Smart Analysis and Decision-Making for Emerging Infectious DiseasesEnrolling by invitationNCT07678619Not applicable
• Effects Of A Rehabilitation Protocol On Muscle Strength, Muscle Fatigue And Postural Control In Post-Dengue And Chikungunya PatientsNot yet recruitingNCT07600879Not applicable
• A Seamless Phase II/III, Observer-blind, to Evaluate Immunogenicity and Safety of Chikungunya Virus Vaccine in Healthy Subjects 12-65Years of Age.RecruitingNCT07555392Phase 2/3
• Xpert® Tropical Fever Test on GeneXpert® Edge X SystemEnrolling by invitationNCT07520279
• An Efficacy, Safety, and Immunogenicity Study of CHIKV VLP Vaccine for the Prevention of Chikungunya Disease in Adolescents and AdultsRecruitingNCT07467707Phase 3
• VLA1553-403 Pregnancy Surveillance StudyEnrolling by invitationNCT07414524
• A Phase I Study of PepGNP-ChikV in Healthy VolunteersNot yet recruitingNCT07394426Early Phase 1
• Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health PerspectiveRecruitingNCT07358910
• Observational Study to Assess the Effectiveness of VLA1553 Vaccine in Preventing Chikungunya During a Pilot Vaccination Strategy in BrazilEnrolling by invitationNCT07347002
• Against Chikungunya Virus and Neonatal InfectionRecruitingNCT07190560Not applicable
• A Clinical Study on the Efficacy and Safety of Reduning Injection in the Treatment of Chikungunya FeverNot yet recruitingNCT07126171Not applicable
• Real-World Study on Chinese Medicine for Treating Chikungunya FeverRecruitingNCT07120724
• Prospective Clinical Registry for Evaluation of Exanthematous Infections and CoinfectionsNot yet recruitingNCT07112846
• Chikungunya Virus Detection in SemenNot yet recruitingNCT06983548Not applicable
• Trial to Evaluate the Immunogenicity and Safety of the Co-administration of Live Attenuated Dengue and Chikungunya Vaccines Compared to Separate Administration in Adults Aged 18 to 59 Years.Not yet recruitingNCT06973772Phase 3
• Real-world Effectiveness, Safety & Immunogenicity of Chikungunya Vaccination: Ambispective Study in Reunion & French GuianaRecruitingNCT06928753Phase 4
• Serological Measurement of Montpellier Professionals' Contacts with Infectious Agents Responsible for Animal-borne DiseasesNot yet recruitingNCT06859619Not applicable
• A Phase 2 Clinical Trial of VLA1553 in Healthy Children Aged 1 to 11 YearsCompletedNCT06106581Phase 2Results posted
• Safety and Immunogenicity of CHIKV VLP Vaccine PXVX0317 in Adults ≥65 YearsCompletedNCT05349617Phase 3Results posted
• A Phase 3 Trial of the VLP-Based Chikungunya Vaccine PXVX0317 (CHIKV VLP Vaccine)CompletedNCT05072080Phase 3Results posted
• A Study to Assess the Safety and Immunogenicity of PXVX0317 Chikungunya Virus Virus-Like Particle VaccineCompletedNCT05065983Phase 2Results posted
• Antibody Persistence And Long Term Safety Of A Chikungunya Virus Vaccine (VLA1553)Active, not recruitingNCT04838444Phase 3Results posted
• Study to Demonstrate Consistency of Three Lots of a Live-attenuated Chikungunya Virus Vaccine Candidate in Healthy AdultsCompletedNCT04786444Phase 3Results posted
• A Multicenter Study to Evaluate Safety and Immunogenicity of a Live-attenuated Chikungunya Vaccine in AdolescentsCompletedNCT04650399Phase 3Results posted
• Pivotal Study to Evaluate Safety and Immunogenicity of a Live-Attenuated Chikungunya Virus Vaccine Candidate in AdultsCompletedNCT04546724Phase 3Results posted
• Phase 1 Study of SAR440894 vs PlaceboCompletedNCT04441905Phase 1Results posted
• Sylvatic Transmission of Zika, Dengue, and Chikungunya Viruses in Thailand and CambodiaCompletedNCT04434846Results posted
• Quantifying the Epidemiological Impact of Targeted Indoor Residual Spraying on Aedes-borne DiseasesCompletedNCT04343521Not applicableResults posted
• Phase 2 Open-label Study of Alum-adjuvanted Chikungunya Virus-like Particle Vaccine (PXVX0317)CompletedNCT03992872Phase 2Results posted
• Chikungunya Vaccine (V184) Study in Previously Exposed Adults (V184-006)CompletedNCT03807843Phase 2Results posted
• Safety, Tolerability and Long-term Immunogenicity of Different Formulations of a Chikungunya Vaccine (V184-005)CompletedNCT03635086Phase 2Results posted
• Trial of a Chikungunya Vaccine, PXVX0317 CHIKV-VLP, in Healthy AdultsCompletedNCT03483961Phase 2Results posted
• Safety, Tolerability, and Immunogenicity of VAL-181388 in Healthy ParticipantsCompletedNCT03325075Phase 1Results posted
• Study of a Live Attenuated Chikungunya Vaccine in a Previously Epidemic AreaCompletedNCT03101111Phase 2Results posted
• Phase II Study to Evaluate Safety and Immunogenicity of a Chikungunya VaccineCompletedNCT02861586Phase 2Results posted
• Trial for Safety and Immunogenicity of a Chikungunya Vaccine, VRC-CHKVLP059-00-VP, in Healthy AdultsCompletedNCT02562482Phase 2Results posted
• A Prospective, Open Label, Treatment Use Study of Patient Safety Following Transfusion of INTERCEPT Platelet ComponentsCompletedNCT02305732Results posted
• Chikungunya Virus Vaccine Trial in Healthy AdultsCompletedNCT01489358Phase 1Results posted
• Using Digital Technology for the Prevention of Aedes-Borne Diseases in Colombian CommunitiesCompletedNCT07517731Not applicable
• Prospective Safety Cohort Study After VLA1553 Vaccination in Municipalities Selected for Participation in the VLA1553 Pilot Vaccination Strategy in BrazilActive, not recruitingNCT07254702
• Assessment of Chikungunya Virus Seroprevalence Before VLA1553 Vaccination in the Municipalities Selected for Participation in the VLA1553 Pilot Vaccination Strategy in BrazilActive, not recruitingNCT07163845
• A Trial to Evaluate the Safety and Immunogenicity of VLA1553 in Healthy ChildrenWithdrawnNCT07133178Phase 3
• A Safety and Immunogenicity Study of CHIKV VLP Vaccine in Children.Active, not recruitingNCT07003984Phase 3
• Trial of an Inactivated Chikungunya Virus VaccineCompletedNCT06669208Phase 1
• The Interest of Systematic Screening for Dengue, Chikungunya, and Zika, in Malaria-negative Return TravelersActive, not recruitingNCT06651372
• Testing Combined IIT-SIT to Control Mosquito-Borne Diseases At ScaleTerminatedNCT06595745Not applicable
• Sustainable Reduction of Dengue in Colombia: Vector Breeding Site Intervention With an Insecticidal CoatingCompletedNCT06268691Not applicable
• Impact of Differential and Systematic Diagnosis of Dengue, Chikungunya and Malaria on Patient Management and Antibiotic Use in West AfricaCompletedNCT06257810Not applicable
• A Clinical Phase 3 Trial of VLA1553 in Adult Participants with Human Immunodeficiency Virus (HIV)WithdrawnNCT06028841Phase 3
• Long-term Follow-up Study to Evaluate Safety and Immunogenicity of CHIKV VLP Single or Booster VaccinationActive, not recruitingNCT06007183Phase 3
• Spatial Repellents for Aedes-borne Virus Control in Sri LankaCompletedNCT05452447Not applicable
• Consequences of a Maternal-fetal Chikungunya Virus InfectionCompletedNCT04909411Not applicable
• Post-Chikungunya Rheumatism - Rheumatology Follow-up of Patients After 15 YearsCompletedNCT04838574
• Clinical Trial to Evaluate the Immunogenicity of Chikungunya VaccineCompletedNCT04603131Phase 1
• Seamless Controlled Trial To Evaluate Safety And Immunogenicity of Chikungunya Vaccine in LatinAmerica and AsiaTerminatedNCT04566484Phase 2/3
• A Cluster-randomized Trial to EValuate the Efficacy of Wolbachia-InfecTed Aedes Aegypti Mosquitoes in Reducing the Incidence of Arboviral Infection in Brazil (EVITA Dengue)CompletedNCT04514107Not applicable
• Yoga for Chronic ChikungunyaTerminatedNCT04455919Not applicable
• Research Study to Assess New Chikungunya and Zika Vaccines in Healthy Adults in Mexico.CompletedNCT04440774Phase 1
• Mobile Point of Care Diagnostic Testing for Ebola Virus Disease in DRCStatus unknownNCT04235361
• Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of mRNA-1944 in Healthy AdultsCompletedNCT03829384Phase 1
• Resistance Exercise Program on the Functionality of Individuals With Chikungunya FeverStatus unknownNCT03702348Early Phase 1
• Genetic Factors and Immunological Determinism of Persistent Consequences of ChikungunyaCompletedNCT03690648
• Impact of Wolbachia Deployment on Arboviral Disease Incidence in Medellin and Bello, ColombiaCompletedNCT03631719
• Safety and Immunogenicity of a Candidate CHIKV Vaccine (CHIK001)CompletedNCT03590392Phase 1
• Investigating Vector-Borne Determinants of Aedes Transmitted Arboviral Infections in Cambodia: An Observational Longitudinal Cohort Study in ChildrenCompletedNCT03534245
• Study to Assess the Safety and Immunogenicity of a Chikungunya Virus Vaccine Candidate (VLA1553) in Healthy VolunteersCompletedNCT03382964Phase 1
• Neurologic Manifestations of the Arbovirus Infection in ColombiaCompletedNCT03206541
• Effects of Auriculotherapy on Pain and Functional Capacity of Individuals With Chikungunya FeverCompletedNCT03090685Not applicable
• Efficacy of Starting Methotrexate Early in Chikungunya ArthritisCompletedNCT03058471Not applicable
• Applying Wolbachia to Eliminate DengueTerminatedNCT03055585Not applicable
• Phase I Trial of Measles Vectored Chikungungya VaccineCompletedNCT03028441Phase 1
• tDCS and Its Therapeutic Effects in CK FeverCompletedNCT02993952Not applicable
• Impact of the Chikungunya Outbreak in Reunion Island on the Quality of Life After 10 YearsCompletedNCT02901509
• The Evaluation of Potential Zika, Chikungunya, and Dengue Infections in MexicoCompletedNCT02831699
• Zika Virus and Related Arbovirus Infections in Deferred Blood Donors (ZVADD)CompletedNCT02794181
• RT-PCR on Urine Samples: Added Value for the Diagnosis of Chikungunya Virus InfectionWithdrawnNCT02714985
• Seroprevalence of Chikungunya at the End of the First Chikungunya Outbreak in the French Antilles Within a Sample of Patients Treated for a HIV InfectionCompletedNCT02553369
• Chikungunya Arthritis in the AmericasCompletedNCT02463968
• Study of the Prognostic Value of Musculoskeletal Ultrasound in Adults With ChikungunyaStatus unknownNCT02281123
• Clinical Evaluation of Anti-CHIKV Hyperimmune Intravenous ImmunoglobulinsStatus unknownNCT02230163Phase 1/2
• The Pilot Study of Chikungunya Virus Infections in Southern TaiwanCompletedNCT02174341
• Cohort of Patients Infected by an ArbovirusStatus unknownNCT01099852
• CuraChik : A Trial of the Efficacy and Safety of Chloroquine as Therapeutic Treatment of Chikungunya DiseaseTerminatedNCT00391313Phase 3

← Chikungunya Fever overview